Bristlecone Advisors, LLC Northwest Biotherapeutics Inc Transaction History
Bristlecone Advisors, LLC
- $1.27 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding NWBO
# of Institutions
13Shares Held
730KCall Options Held
0Put Options Held
0-
Moloney Securities Asset Management, LLC489KShares$170,9820.02% of portfolio
-
Vsm Wealth Advisory, LLC Hunt Valley, MD65.6KShares$22,9500.01% of portfolio
-
Opus Capital Group, LLC60.2KShares$21,0520.0% of portfolio
-
Williams Jones Wealth Management, Llc. New York, NY27KShares$9,4500.0% of portfolio
-
Ethos Financial Group, LLC King Of Prussia, PA23.7KShares$8,2950.0% of portfolio
About NORTHWEST BIOTHERAPEUTICS INC
- Ticker NWBO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,037,230,016
- Market Cap $363M
- Description
- Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, wh...